Year To Quarter End Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7730550

Concept 2017-03-01 to
2017-11-30
2016-03-01 to
2016-11-30
Year to quarter end statement of income
Statement of income
Net sales
109,553,000,000 JPY
109,729,000,000 JPY
Cost of sales
40,267,000,000 JPY
38,778,000,000 JPY
Gross profit (loss)
69,285,000,000 JPY
70,951,000,000 JPY
Selling, general and administrative expenses
48,598,000,000 JPY
48,955,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
20,687,000,000 JPY
21,995,000,000 JPY
Non-operating income
Interest income
302,000,000 JPY
169,000,000 JPY
Dividend income
501,000,000 JPY
467,000,000 JPY
Non-operating income
1,718,000,000 JPY
1,146,000,000 JPY
Non-operating expenses
Interest expenses
25,000,000 JPY
29,000,000 JPY
Non-operating expenses
361,000,000 JPY
256,000,000 JPY
Ordinary profit (loss)
22,043,000,000 JPY
22,885,000,000 JPY
Extraordinary income
Extraordinary income
487,000,000 JPY
4,198,000,000 JPY
Extraordinary losses
Extraordinary losses
6,000,000 JPY
52,000,000 JPY
Profit (loss) before income taxes
22,524,000,000 JPY
27,031,000,000 JPY
Income taxes
6,478,000,000 JPY
8,551,000,000 JPY
Profit (loss)
16,046,000,000 JPY
18,480,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.